07:15 AM EDT, 08/18/2025 (MT Newswires) -- FibroGen ( FGEN ) said Monday that the China State Administration for Market Regulation has approved the sale of its Chinese unit to a subsidiary of AstraZeneca ( AZN ) .

The company announced the deal in February, saying it has agreed to sell FibroGen International (Hong Kong) for about $160 million.

FibroGen ( FGEN ) said it expects to close the transaction in Q3, subject to other contractual closing conditions.